These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 17459771

  • 1. Assessment of efficacy of pharmacotherapy for ventricular tachycardia.
    Cooper MJ.
    Heart Lung Circ; 2007 Jun; 16(3):170-5. PubMed ID: 17459771
    [Abstract] [Full Text] [Related]

  • 2. Management of ventricular arrhythmias.
    Aronow WS.
    Compr Ther; 1988 Aug; 14(8):25-30. PubMed ID: 3048863
    [Abstract] [Full Text] [Related]

  • 3. [Drug therapy of ventricular tachycardia].
    Hermida JS, Jarry G, Rey JL, Quiret JC.
    Arch Mal Coeur Vaiss; 1998 Mar; 91 Spec No 1():15-20. PubMed ID: 9749280
    [Abstract] [Full Text] [Related]

  • 4. [Is programmed ventricular stimulation still up to date in the medicinal evaluation of ventricular tachycardia?].
    Kouakam C, Guédon-Moreau L, Kacet S.
    Therapie; 1998 Mar; 53(6):533-41. PubMed ID: 10070230
    [Abstract] [Full Text] [Related]

  • 5. [Ventricular pro-arrhythmic effects of anti-arrhythmia drugs].
    Jaillon P, Simon T.
    Therapie; 1992 Mar; 47(3):187-92. PubMed ID: 1295119
    [Abstract] [Full Text] [Related]

  • 6. Surgery and ablative therapy for ventricular tachycardia.
    Ross DL.
    Heart Lung Circ; 2007 Jun; 16(3):214-21. PubMed ID: 17446128
    [Abstract] [Full Text] [Related]

  • 7. [Acute treatment of stable hemodynamically tolerable ventricular tachycardia].
    Haverkamp W, Rolf S, Stockburger M, Dietz R.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):207-12. PubMed ID: 15832239
    [Abstract] [Full Text] [Related]

  • 8. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S, Murawski MM.
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
    Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN, MUSTT Investigators.
    J Am Coll Cardiol; 2007 Sep 18; 50(12):1150-7. PubMed ID: 17868806
    [Abstract] [Full Text] [Related]

  • 11. A focus on when and when not to use antiarrhythmic drugs in treating ventricular arrhythmias and indications for the use of automatic implantable cardioverter-defibrillators.
    Aronow WS.
    Geriatrics; 2008 Aug 18; 63(8):20-8. PubMed ID: 18672953
    [Abstract] [Full Text] [Related]

  • 12. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP, Winters SL, Subacius H, Berger RD, Ellenbogen KA, Taylor SG, Schaechter A, Howard A, Kadish A, Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Pacing Clin Electrophysiol; 2009 Jun 18; 32(6):755-61. PubMed ID: 19545338
    [Abstract] [Full Text] [Related]

  • 13. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
    Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P.
    Circulation; 2008 Jan 29; 117(4):462-9. PubMed ID: 18172038
    [Abstract] [Full Text] [Related]

  • 14. [How to develop an anti-arrhythmia agent in 1990. The cardiologist's viewpoint].
    Touboul P.
    Arch Mal Coeur Vaiss; 1991 Feb 29; 84 Spec No 2():57-62. PubMed ID: 1726997
    [Abstract] [Full Text] [Related]

  • 15. Pharmacologic therapy of ventricular tachycardia using electrophysiologic techniques.
    Kutalek SP.
    Cardiol Clin; 1986 Aug 29; 4(3):473-86. PubMed ID: 3530469
    [Abstract] [Full Text] [Related]

  • 16. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques.
    Colella A, Pieragnoli P, Ricciardi G, Giaccardi M, Padeletti L, Michelucci A.
    Minerva Cardioangiol; 2007 Jun 29; 55(3):341-51. PubMed ID: 17534253
    [Abstract] [Full Text] [Related]

  • 17. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S, Duker G, Carlsson L.
    Prog Biophys Mol Biol; 2008 Jun 29; 98(2-3):328-39. PubMed ID: 19038282
    [Abstract] [Full Text] [Related]

  • 18. [Out-of- or in-hospital occurrences of malignant ventricular tachyarrhythmias: the prognostic significance in the population enrolled in the AVID study. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E.
    Ital Heart J Suppl; 2000 Apr 29; 1(4):579-80. PubMed ID: 10832150
    [No Abstract] [Full Text] [Related]

  • 19. [Pertinence of animal and human models in the evaluation of ventricular anti-arrhythmia agents].
    Funck-Brentano C, Le Heuzey JY.
    Arch Mal Coeur Vaiss; 1991 Feb 29; 84 Spec No 2():15-20. PubMed ID: 1726994
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of procainamide challenge for electrophysiologic arrhythmia risk stratification.
    Schreibman DS, McPherson CA, Rosenfeld LE, Batsford WP, Lampert R.
    Am J Cardiol; 2004 Dec 01; 94(11):1435-8. PubMed ID: 15566921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.